ALCL and Breast Implants
Plastic and Reconstructive Surgery
In late January 2011, the FDA issued a statement potentially linking Breast Implants and Anaplastic Large Cell Lymphoma.
PRS is pleased to present this collection of high quality scientific data on this serious subject.
The views, opinions and techniques set forth in this collection addressing anaplastic large cell lymphoma in women with breast implants are those of the individual author(s) and do not necessarily reflect the views, opinions, or recommendations of the American Society of Plastic Surgeons, the Journal or the Journal editors. Any treatment recommendations contained in the article are those of the individual author(s) and are not to be considered or construed as practice guidelines, practice standards or practice parameters. The use of any treatment technique described in the article is at the sole discretion of the physician in the exercise of his or her independent medical judgment taking into account the patient’s individual circumstances.
Rod J. Rohrich, MD